Anavex Life Sciences Corp. (AVXL)
4.42
+0.06
(+1.38%)
USD |
NASDAQ |
Feb 25, 11:16
Anavex Life Sciences Market Cap : 409.61M for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 41.66M |
| Cabaletta Bio, Inc. | 353.29M |
| CorMedix, Inc. | 566.89M |
| Verastem, Inc. | 444.39M |
| Ocugen, Inc. | 607.18M |
Market Cap Related Metrics
| Price to Book Value | 3.235 |
| Price | 4.42 |
| Earnings Yield | -10.52% |